MAPT and Alzheimer disease: Upregulation of phosphorylated microtubule-associated protein tau (MAPT) and consequently altered mitochondrial functions are associated with Alzheimer’s disease [114]; in cancer, MAPT overexpression is linked to poor prognosis and drug resistance [115].